Matches in SemOpenAlex for { <https://semopenalex.org/work/W2586642802> ?p ?o ?g. }
- W2586642802 endingPage "4069" @default.
- W2586642802 startingPage "4055" @default.
- W2586642802 abstract "Background and Purpose Inflammation plays a key role in atherosclerosis. The protective role of angiotensin 1–7 (Ang-(1–7)) in vascular pathologies suggested the therapeutic use of low MW, non-peptide Ang-(1–7) mimetics, such as AVE0991. The mechanisms underlying the vaso-protective effects of AVE0991, a Mas receptor agonist, remain to be explored. Experimental Approach We investigated the effects of AVE0991 on the spontaneous atherosclerosis in apolipoprotein E (ApoE)−/− mice, in the context of vascular inflammation and plaque stability. Key Results AVE0991 has significant anti-atherosclerotic properties in ApoE−/− mice and increases plaque stability, by reducing plaque macrophage content, without effects on collagen. Using the descending aorta of chow-fed ApoE−/− mice, before significant atherosclerotic plaque develops, we gained insight to early events in atherosclerosis. Interestingly, perivascular adipose tissue (PVAT) and adventitial infiltration with macrophages and T-cells precedes atherosclerotic plaque or the impairment of endothelium-dependent NO bioavailability (a measure of endothelial function). AVE0991 inhibited perivascular inflammation, by reducing chemokine expression in PVAT and through direct actions on monocytes/macrophages inhibiting their activation, characterized by production of IL-1β, TNF-α, CCL2 and CXCL10, and differentiation to M1 phenotype. Pretreatment with AVE0991 inhibited migration of THP-1 monocytes towards supernatants of activated adipocytes (SW872). Mas receptors were expressed in PVAT and in THP-1 cells in vitro, and the anti-inflammatory effects of AVE0991 were partly Mas dependent. Conclusions and Implications The selective Mas receptor agonist AVE0991 exhibited anti-atherosclerotic and anti-inflammatory actions, affecting monocyte/macrophage differentiation and recruitment to the perivascular space during early stages of atherosclerosis in ApoE−/− mice. Linked Articles This article is part of a themed section on Targeting Inflammation to Reduce Cardiovascular Disease Risk. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.22/issuetoc and http://onlinelibrary.wiley.com/doi/10.1111/bcp.v82.4/issuetoc" @default.
- W2586642802 created "2017-02-17" @default.
- W2586642802 creator A5000650554 @default.
- W2586642802 creator A5009703758 @default.
- W2586642802 creator A5020577597 @default.
- W2586642802 creator A5030510453 @default.
- W2586642802 creator A5038463084 @default.
- W2586642802 creator A5039650644 @default.
- W2586642802 creator A5051568923 @default.
- W2586642802 creator A5063556944 @default.
- W2586642802 creator A5064027383 @default.
- W2586642802 creator A5074974116 @default.
- W2586642802 creator A5078917807 @default.
- W2586642802 creator A5086285174 @default.
- W2586642802 date "2017-02-01" @default.
- W2586642802 modified "2023-10-16" @default.
- W2586642802 title "Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis" @default.
- W2586642802 cites W1021705890 @default.
- W2586642802 cites W1512110535 @default.
- W2586642802 cites W1538839647 @default.
- W2586642802 cites W1593555249 @default.
- W2586642802 cites W1596457615 @default.
- W2586642802 cites W1736623295 @default.
- W2586642802 cites W1858019744 @default.
- W2586642802 cites W1861425906 @default.
- W2586642802 cites W1888470382 @default.
- W2586642802 cites W1902188197 @default.
- W2586642802 cites W1966863790 @default.
- W2586642802 cites W1968908220 @default.
- W2586642802 cites W1969893456 @default.
- W2586642802 cites W1974985368 @default.
- W2586642802 cites W1979041826 @default.
- W2586642802 cites W1980841695 @default.
- W2586642802 cites W1986194263 @default.
- W2586642802 cites W1986326642 @default.
- W2586642802 cites W1993746543 @default.
- W2586642802 cites W2004840558 @default.
- W2586642802 cites W2010218102 @default.
- W2586642802 cites W2015385554 @default.
- W2586642802 cites W2033684886 @default.
- W2586642802 cites W2033896075 @default.
- W2586642802 cites W2035192731 @default.
- W2586642802 cites W2038563245 @default.
- W2586642802 cites W2047324192 @default.
- W2586642802 cites W2050548878 @default.
- W2586642802 cites W2054960859 @default.
- W2586642802 cites W2063666661 @default.
- W2586642802 cites W2072029769 @default.
- W2586642802 cites W2072052992 @default.
- W2586642802 cites W2073054137 @default.
- W2586642802 cites W2076522158 @default.
- W2586642802 cites W2083481797 @default.
- W2586642802 cites W2084048794 @default.
- W2586642802 cites W2090826353 @default.
- W2586642802 cites W2091525986 @default.
- W2586642802 cites W2094629035 @default.
- W2586642802 cites W2096626379 @default.
- W2586642802 cites W2105279305 @default.
- W2586642802 cites W2115006322 @default.
- W2586642802 cites W2131167889 @default.
- W2586642802 cites W2134071881 @default.
- W2586642802 cites W2136208700 @default.
- W2586642802 cites W2137329488 @default.
- W2586642802 cites W2138043907 @default.
- W2586642802 cites W2144268955 @default.
- W2586642802 cites W2150478000 @default.
- W2586642802 cites W2153626991 @default.
- W2586642802 cites W2154073422 @default.
- W2586642802 cites W2159160683 @default.
- W2586642802 cites W2159198711 @default.
- W2586642802 cites W2169328873 @default.
- W2586642802 cites W2193975711 @default.
- W2586642802 cites W2194756172 @default.
- W2586642802 cites W2196303538 @default.
- W2586642802 cites W2210812545 @default.
- W2586642802 cites W2228495115 @default.
- W2586642802 cites W2278065343 @default.
- W2586642802 cites W2323572153 @default.
- W2586642802 cites W2337180881 @default.
- W2586642802 cites W2337424843 @default.
- W2586642802 cites W2401178740 @default.
- W2586642802 cites W2471514705 @default.
- W2586642802 cites W2521306464 @default.
- W2586642802 cites W2556679061 @default.
- W2586642802 cites W2586642802 @default.
- W2586642802 cites W2993595994 @default.
- W2586642802 cites W3217532623 @default.
- W2586642802 doi "https://doi.org/10.1111/bph.13685" @default.
- W2586642802 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5659999" @default.
- W2586642802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27935022" @default.
- W2586642802 hasPublicationYear "2017" @default.
- W2586642802 type Work @default.
- W2586642802 sameAs 2586642802 @default.
- W2586642802 citedByCount "85" @default.
- W2586642802 countsByYear W25866428022017 @default.
- W2586642802 countsByYear W25866428022018 @default.
- W2586642802 countsByYear W25866428022019 @default.
- W2586642802 countsByYear W25866428022020 @default.